• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Evaluating Conversion of Low-Grade to High-Grade Appendiceal Neoplasms for Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.

作者信息

Mangieri Christopher W, Levine Edward A

机构信息

Division of Surgical Oncology, Wake Forest Baptist Health Medical Center, Winston-Salem, NC, USA.

出版信息

Ann Surg Oncol. 2022 Jan;29(1):212-213. doi: 10.1245/s10434-021-10717-4. Epub 2021 Sep 1.

DOI:10.1245/s10434-021-10717-4
PMID:34467501
Abstract
摘要

相似文献

1
ASO Author Reflections: Evaluating Conversion of Low-Grade to High-Grade Appendiceal Neoplasms for Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.ASO作者反思：评估低级别阑尾肿瘤向高级别阑尾肿瘤的转化，以进行重复的细胞减灭术联合腹腔热灌注化疗。
Ann Surg Oncol. 2022 Jan;29(1):212-213. doi: 10.1245/s10434-021-10717-4. Epub 2021 Sep 1.
2
ASO Author Reflections: When is the Best Time to Perform Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for a Recurrent Low-Grade Appendiceal Mucinous Neoplasm?ASO作者反思：对于复发性低级别阑尾黏液性肿瘤，何时是进行重复细胞减灭术联合腹腔热灌注化疗的最佳时机？
Ann Surg Oncol. 2022 Jun;29(6):3432-3433. doi: 10.1245/s10434-022-11515-2. Epub 2022 Mar 7.
3
ASO Author Reflections: Neoadjuvant Chemotherapy for High-Grade Appendiceal Neoplasms Before Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy, Closer to Evidence-Based Practice?ASO作者反思：在进行细胞减灭术联合热灌注化疗之前，对高级别阑尾肿瘤进行新辅助化疗，是否更接近循证医学实践？
Ann Surg Oncol. 2022 Apr;29(4):2649-2650. doi: 10.1245/s10434-021-11165-w. Epub 2022 Jan 10.
4
ASO Author Reflections: Disparate Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Based on Insurance Status.ASO作者反思：基于保险状况的减瘤手术联合热灌注化疗后的不同结局
Ann Surg Oncol. 2022 Jan;29(1):260-261. doi: 10.1245/s10434-021-10748-x. Epub 2021 Aug 28.
5
ASO Author Reflections: Significance of Primary Tumor Location and Genomic Alterations in Colorectal Peritoneal Metastases and Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy.ASO作者反思：原发性肿瘤位置和基因组改变在结直肠癌腹膜转移及细胞减灭术-热灌注化疗中的意义
Ann Surg Oncol. 2023 Jul;30(7):4471-4472. doi: 10.1245/s10434-023-13522-3. Epub 2023 Apr 27.
6
ASO Author Reflections: Thirty Years of Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at Wake Forest University.ASO作者反思：维克森林大学开展热灌注化疗（HIPEC）联合重复细胞减灭术三十年
Ann Surg Oncol. 2022 Jun;29(6):3446-3447. doi: 10.1245/s10434-022-11514-3. Epub 2022 Mar 11.
7
ASO Author Reflections: AJCC 8th Edition Performs Well in Predicting Outcomes Among Patients with Disseminated Appendiceal Cancer Undergoing CRS/HIPEC.ASO作者反思：美国癌症联合委员会第8版在预测接受CRS/HIPEC的播散性阑尾癌患者的预后方面表现良好。
Ann Surg Oncol. 2023 Sep;30(9):5754-5755. doi: 10.1245/s10434-023-13740-9. Epub 2023 Jun 15.
8
ASO Author Reflections: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).ASO作者反思：微卫星和RAS/RAF突变状态作为接受减瘤手术和腹腔内热灌注化疗（HIPEC）治疗的结直肠癌腹膜转移的预后因素
Ann Surg Oncol. 2022 Jun;29(6):3418-3419. doi: 10.1245/s10434-021-11057-z. Epub 2021 Nov 6.
9
ASO Author Reflections: Augmenting Clinical Decision-Making Around Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Through Traditional and Machine Learning Algorithms.ASO作者反思：通过传统算法和机器学习算法，利用腹腔热灌注化疗增强减瘤手术周围的临床决策制定。
Ann Surg Oncol. 2023 Sep;30(9):5443-5444. doi: 10.1245/s10434-023-13716-9. Epub 2023 Jun 2.
10
ASO Author Reflections: Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer with Peritoneal Carcinomatosis: A Systematic Review and Meta-Analysis.ASO作者反思：减瘤手术联合腹腔热灌注化疗治疗伴腹膜转移的胃癌：一项系统评价和荟萃分析
Ann Surg Oncol. 2022 Nov;29(12):7538-7539. doi: 10.1245/s10434-022-12317-2. Epub 2022 Jul 30.

引用本文的文献

1
ASO Author Reflections: Neoadjuvant Oxaliplatin Therapy for Peritoneal Carcinomatosis, Any Impact on Subsequent Hyperthermic Intraperitoneal Chemotherapy Perfusion?ASO作者反思：新辅助奥沙利铂治疗腹膜癌，对后续腹腔热灌注化疗有何影响？
Ann Surg Oncol. 2023 Apr;30(4):2494-2495. doi: 10.1245/s10434-022-13009-7. Epub 2023 Jan 5.